Cargando…
Infliximab Extends the Duration until the First Surgery in Patients with Crohn's Disease
Background/Aims. While biological drugs are useful for relieving the disease activity and preventing abdominal surgery in patients with Crohn's disease (CD), it is unclear whether the use of biological drugs in CD patients with no history of abdominal surgery is appropriate. We evaluated the ef...
Autores principales: | Sakatani, Aki, Fujiya, Mikihiro, Ito, Takahiro, Inaba, Yuhei, Ueno, Nobuhiro, Kashima, Shin, Tominaga, Motoya, Moriichi, Kentaro, Okamoto, Kotaro, Tanabe, Hiroki, Ikuta, Katsuya, Ohtake, Takaaki, Kono, Toru, Furukawa, Hiroyuki, Ashida, Toshifumi, Kohgo, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858862/ https://www.ncbi.nlm.nih.gov/pubmed/24371835 http://dx.doi.org/10.1155/2013/879491 |
Ejemplares similares
-
A Randomized Study on the Effectiveness of Prophylactic Clipping during Endoscopic Resection of Colon Polyps for the Prevention of Delayed Bleeding
por: Dokoshi, Tatsuya, et al.
Publicado: (2015) -
A Bamboo Joint-Like Appearance is a Characteristic Finding in the Upper Gastrointestinal Tract of Crohn's Disease Patients: A Case-Control Study
por: Fujiya, Mikihiro, et al.
Publicado: (2015) -
Increased dosage of infliximab is a potential cause of Pneumocystis carinii pneumonia
por: Iwama, Takuya, et al.
Publicado: (2016) -
Development of pulmonary sarcoidosis in Crohn’s disease patient under infliximab biosimilar treatment after long-term original infliximab treatment: a case report and literature review
por: Kashima, Shin, et al.
Publicado: (2021) -
A case report of drug-induced liver injury due to the infliximab biosimilar
CT-P13 on switching from original infliximab in a patient with Crohn’s
disease
por: Kashima, Shin, et al.
Publicado: (2022)